DEA schedule

Is Natesto a controlled substance?

Natesto contains testosterone. Federal schedule from the FDA NDC directory, checked against the DEA controlled substances list.

Source: FDA NDC Directory file dated 2026-10-22. Publisher page

Yes. Natesto (testosterone) is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Testosterone (Schedule III).

Run it in Rivvi

Which 2027 plans near you dropped or restricted Natesto?

Tier changes and new prior auth, step therapy or quantity limits, plan by plan.

Free to start. Opens Rivvi, the AI workspace for healthcare teams.

Schedule check

Schedule sources for Natesto
SourceWhat it lists
FDA NDC directory1 prescription listings from 1 labelers, all Schedule III
DEA controlled substances listTestosterone: Schedule III

DEA list entry

DEA list entries for testosterone
SubstanceDEA codeScheduleNarcoticOther namesMatch
Testosterone (17β-hydroxyandrost-4-en-3-one)4000IIINoAndroid-T; Androlan; Depotest; DelatestrylListed by name

Natesto NDC listings

NDC listings for Natesto
NDCProductFormStrengthLabelerDEA schedule
42667-5511Natesto nasal gelgel, metered5.5 mg/.122gAcerus Pharmaceuticals CorporationCIII

Questions

Is Natesto a controlled substance?

Yes. Natesto (testosterone) is a Schedule III controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Testosterone (Schedule III).

Is Natesto a narcotic?

No. The DEA list does not mark testosterone as a narcotic (NARC = N) and places it in Schedule III. Its FDA established pharmacologic class is Androgen.

What schedule is Natesto?

Natesto is Schedule III in the FDA NDC directory, which matches the DEA controlled substances list.

Does this page cover state schedules?

No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.

More on Natesto

Try it on your own data today.

Free to start. Most teams are using it the same day.